Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.11451 | 46 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.11739 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.10934 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.08075 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.92589 | 42 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.15986 | 46 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.21527 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.19976 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.10239 | 48 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.06854 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.09135 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.04185 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.1145 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.10811 | 47 |